1. 498PPhase I/II study of valproic acid (VPA) and short-course radiotherapy (SCRT) plus capecitabine (CAP) as preoperative treatment in low-moderate risk rectal cancer (V-shoRT-R3). (23rd October 2018) Authors: Budillon, A; Delrio, P; Pecori, B; Tatangelo, F; Di Gennaro, E; Romano, C; D'Angelo, V; Marone, P; Granata, C; Cavalacanti, E; De Stefano, A; Pace, U; Bianco, F; Petrillo, A; Lastoria, S; Botti, G; Muto, P; Perrone, F; Piccirillo, M C; Avallone, A Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial. Issue 2 (February 2021) Authors: Pignata, Sandro; Lorusso, Domenica; Joly, Florence; Gallo, Ciro; Colombo, Nicoletta; Sessa, Cristiana; Bamias, Aristotelis; Salutari, Vanda; Selle, Frédèric; Frezzini, Simona; De Giorgi, Ugo; Pautier, Patricia; Bologna, Alessandra; Orditura, Michele; Dubot, Coraline; Gadducci, Angiolo; Mammoliti,... Journal: Lancet oncology Issue: Volume 22:Issue 2(2021) Page Start: 267 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. D12 Faulty linear and back-splicing in Huntington's disease: novel players in the pathologic process hint at innovative RNA biomarkers. (12th September 2022) Authors: Pellegrini, Miguel; Ayyildiz, Dilara; Bergonzoni, Guendalina; Monziani, Alan; Tripathi, Takshashila; Döring, Jessica; Cardamone, Giulia; Kerschbamer, Emanuela; Di Leva, Francesca; Perrone, F; Abruzzese, MP; Busi, LC; Asselta, Rosanna; Pennati, Elia; Donini, Luisa; Zasso, Jacopo; Conti, Luciano; W... Journal: Journal of neurology, neurosurgery and psychiatry Issue: Volume 93(2022)Supplement 1 Page Start: A24 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Deficiencies in health-related quality-of-life assessment and reporting: a systematic review of oncology randomized phase III trials published between 2012 and 2016. (10th October 2018) Authors: Marandino, L; La Salvia, A; Sonetto, C; De Luca, E; Pignataro, D; Zichi, C; Di Stefano, R F; Ghisoni, E; Lombardi, P; Mariniello, A; Reale, M L; Trevisi, E; Leone, G; Muratori, L; Marcato, M; Bironzo, P; Novello, S; Aglietta, M; Scagliotti, G V; Perrone, F Journal: Annals of oncology Issue: Volume 29:Number 12(2018) Page Start: 2288 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. O-025A randomized, multicenter, phase 2 trial comparing CAPTEM versus FOLFIRI as second-line treatment for MGMT-methylated, RAS-mutated metastatic colorectal cancer patients. (2nd July 2019) Authors: Pietrantonio, F; Lobefaro, R; Antista, M; Miceli, R; Raimondi, A; Lonardi, S; Rimassa, L; Saggio, S; Capone, I; Farina, G; Longarini, R; Mosconi, S; Bianchi, A Sartore; Tomasello, G; Petrelli, F; Murgioni, S; Perrone, F; Barault, L; Milione, M; Nicolantonio, F Di Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Oral glutamine in the prevention of fluorouracil induced intestinal toxicity: a double blind, placebo controlled, randomised trial. Issue 1 (1st January 2001) Authors: Daniele, B; Perrone, F; Gallo, C; Pignata, S; De Martino, S; De Vivo, R; Barletta, E; Tambaro, R; Abbiati, R; D'Agostino, L Journal: Gut Issue: Volume 48:Issue 1(2001) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P-108Quality of life assessment and reporting in colorectal cancer: a systematic review of phase 3 trials published between 2012 and 2018. (2nd July 2019) Authors: Lombardi, P; Marandino, L; De Luca, E; Zichi, C; Pignataro, D; Di Stefano, R; Ghisoni, E; Mariniello, A; Reale, M; Trevisi, E; Gianmarco, L; Muratori, L; La Salvia, A; Sonetto, C; Leone, F; Aglietta, M; Novello, S; Scagliotti, G; Perrone, F; Di Maio, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancer. (16th February 2018) Authors: Piccirillo, M C; Scambia, G; Bologna, A; Signoriello, S; Vergote, I; Baumann, K; Lorusso, D; Murgia, V; Sorio, R; Ferrandina, G; Sacco, C; Cormio, G; Breda, E; Cinieri, S; Natale, D; Mangili, G; Pisano, C; Cecere, S C; Di Napoli, M; Salutari, V Journal: Annals of oncology Issue: Volume 29:Number 5(2018) Page Start: 1189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Reply to the letter to the editor 'On the underreporting of health-related quality of life and regulatory approval' by Bhamidipati et al. (29th January 2019) Authors: Di Maio, M; Marandino, L; Perrone, F Journal: Annals of oncology Issue: Volume 30:Number 4(2019) Page Start: 658 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗